To see if certain variations in the CYP2B6 gene contribute to differences in plasma drug levels and central nervous system side affects in people who take nevirapine or efavirenz.
Study Type
INTERVENTIONAL
Allocation
NON_RANDOMIZED
Purpose
HEALTH_SERVICES_RESEARCH
Masking
NONE
Enrollment
33
single oral dose 200mg of nevirapine and single oral dose 600 mg of efavirenz
Pharmacokinetics of single dose nevirapine and single dose efavirenz
Time frame: 5-6 weeks
This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.